Nov 29, 2018
Concordia International Corp. Announces Name Change to ADVANZ PHARMA Corp.
Nov 14, 2018
Concordia International Corp. Announces Third Quarter 2018 Results
Oct 29, 2018
Concordia International Corp. Adds European Pharmaceutical Industry Expert to its Board of Directors
Oct 15, 2018
Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors
Oct 09, 2018
Concordia International Corp. Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization
Sep 11, 2018
Concordia International Corp. Provides Update On Its Recently Completed Recapitalization Transaction
Aug 08, 2018
Concordia International Corp. Announces Second Quarter 2018 Results
Jul 25, 2018
Concordia International Corp. Announces Release Date for Second Quarter 2018 Results
May 31, 2018
Concordia International Corp. Provides Corporate Update
May 28, 2018
Concordia International Corp. Announces Changes to its Board of Directors
May 15, 2018
Concordia International Corp. Announces First Quarter 2018 Results
Mar 08, 2018
Concordia International Corp. Announces Fourth Quarter and Fiscal 2017 Results
Feb 21, 2018
Concordia International Corp. Announces Release Date for Fourth Quarter and Year-End 2017 Results
Dec 15, 2017
Concordia International Corp. Comments on Recent Trading Activity
Nov 21, 2017
Concordia International Corp. Comments on CMA Statement of Objections Related to Liothyronine
Nov 14, 2017
Concordia International Corp. Announces Third Quarter 2017 Results
Sep 06, 2017
Concordia International Corp. Announces DELIVER Strategy
Aug 11, 2017
Concordia International Corp. Announces Second Quarter 2017 Results
Jun 21, 2017
Concordia International Corp. Provides Update on Development of Long-Term Growth Strategy
Jun 13, 2017
Concordia International Corp. Announces RedHill Biopharma Has Started Promoting Donnatal® in the U.S.